These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
402 related articles for article (PubMed ID: 33437209)
1. P Kamprom W; Tawonsawatruk T; Mas-Oodi S; Anansilp K; Rattanasompattikul M; Supokawej A Int J Med Sci; 2021; 18(3):744-755. PubMed ID: 33437209 [TBL] [Abstract][Full Text] [Related]
2. Impacts of Indoxyl Sulfate and p-Cresol Sulfate on Chronic Kidney Disease and Mitigating Effects of AST-120. Liu WC; Tomino Y; Lu KC Toxins (Basel); 2018 Sep; 10(9):. PubMed ID: 30208594 [TBL] [Abstract][Full Text] [Related]
3. Protein-bound uremic toxins: new culprits of cardiovascular events in chronic kidney disease patients. Ito S; Yoshida M Toxins (Basel); 2014 Feb; 6(2):665-78. PubMed ID: 24561478 [TBL] [Abstract][Full Text] [Related]
5. Uremic toxins impair human bone marrow-derived mesenchymal stem cells functionality in vitro. Idziak M; Pędzisz P; Burdzińska A; Gala K; Pączek L Exp Toxicol Pathol; 2014 Jul; 66(4):187-94. PubMed ID: 24548687 [TBL] [Abstract][Full Text] [Related]
6. SLC22A11 Inserts the Uremic Toxins Indoxyl Sulfate and P-Cresol Sulfate into the Plasma Membrane. Tust M; Müller JP; Fischer D; Gründemann D Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894870 [TBL] [Abstract][Full Text] [Related]
7. Uremic Toxins Activates Na/K-ATPase Oxidant Amplification Loop Causing Phenotypic Changes in Adipocytes in In Vitro Models. Bartlett DE; Miller RB; Thiesfeldt S; Lakhani HV; Khanal T; D Pratt R; Cottrill CL; Klug RL; Adkins NS; Bown PC; Nease DB; Shapiro JI; Sodhi K Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30201874 [TBL] [Abstract][Full Text] [Related]
8. Exploring binding characteristics and the related competition of different protein-bound uremic toxins. Deltombe O; de Loor H; Glorieux G; Dhondt A; Van Biesen W; Meijers B; Eloot S Biochimie; 2017 Aug; 139():20-26. PubMed ID: 28528271 [TBL] [Abstract][Full Text] [Related]
9. Contribution of Gut Microbiota-Derived Uremic Toxins to the Cardiovascular System Mineralization. Filipska I; Winiarska A; Knysak M; Stompór T Toxins (Basel); 2021 Apr; 13(4):. PubMed ID: 33920096 [TBL] [Abstract][Full Text] [Related]
10. Effects of Uremic Toxins from the Gut Microbiota on Bone: A Brief Look at Chronic Kidney Disease. Black AP; Cardozo LF; Mafra D Ther Apher Dial; 2015 Oct; 19(5):436-40. PubMed ID: 25944654 [TBL] [Abstract][Full Text] [Related]
11. Rapid and sustainable HPLC method for the determination of uremic toxins in human plasma samples. Silva LAP; Campagnolo S; Fernandes SR; Marques SS; Barreiros L; Sampaio-Maia B; Segundo MA Anal Bioanal Chem; 2023 Feb; 415(4):683-694. PubMed ID: 36464734 [TBL] [Abstract][Full Text] [Related]
12. Removal of protein-bound, hydrophobic uremic toxins by a combined fractionated plasma separation and adsorption technique. Brettschneider F; Tölle M; von der Giet M; Passlick-Deetjen J; Steppan S; Peter M; Jankowski V; Krause A; Kühne S; Zidek W; Jankowski J Artif Organs; 2013 Apr; 37(4):409-16. PubMed ID: 23330821 [TBL] [Abstract][Full Text] [Related]
13. Suppression of Klotho expression by protein-bound uremic toxins is associated with increased DNA methyltransferase expression and DNA hypermethylation. Sun CY; Chang SC; Wu MS Kidney Int; 2012 Apr; 81(7):640-50. PubMed ID: 22237753 [TBL] [Abstract][Full Text] [Related]
14. Gut microbiota generation of protein-bound uremic toxins and related metabolites is not altered at different stages of chronic kidney disease. Gryp T; De Paepe K; Vanholder R; Kerckhof FM; Van Biesen W; Van de Wiele T; Verbeke F; Speeckaert M; Joossens M; Couttenye MM; Vaneechoutte M; Glorieux G Kidney Int; 2020 Jun; 97(6):1230-1242. PubMed ID: 32317112 [TBL] [Abstract][Full Text] [Related]
15. Protein-bound uremic toxins induce tissue remodeling by targeting the EGF receptor. Sun CY; Young GH; Hsieh YT; Chen YH; Wu MS; Wu VC; Lee JH; Lee CC J Am Soc Nephrol; 2015 Feb; 26(2):281-90. PubMed ID: 25012179 [TBL] [Abstract][Full Text] [Related]
16. Molecular and Cellular Mechanisms that Induce Arterial Calcification by Indoxyl Sulfate and P-Cresyl Sulfate. Opdebeeck B; D'Haese PC; Verhulst A Toxins (Basel); 2020 Jan; 12(1):. PubMed ID: 31963891 [TBL] [Abstract][Full Text] [Related]
17. Assessment of uremic toxins in advanced chronic kidney disease patients on maintenance hemodialysis by LC-ESI-MS/MS. Ragi N; Pallerla P; Babi Reddy Gari AR; Lingampelly SS; Ketavarapu V; Addipilli R; Chirra N; Kantevari S; Yadla M; Sripadi P Metabolomics; 2023 Feb; 19(3):14. PubMed ID: 36826619 [TBL] [Abstract][Full Text] [Related]
18. The Effect of Sevelamer on Serum Levels of Gut-Derived Uremic Toxins: Results from In Vitro Experiments and A Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial. Bennis Y; Cluet Y; Titeca-Beauport D; El Esper N; Ureña P; Bodeau S; Combe C; Dussol B; Fouque D; Choukroun G; Liabeuf S Toxins (Basel); 2019 May; 11(5):. PubMed ID: 31109001 [TBL] [Abstract][Full Text] [Related]
19. Serum total p-cresol and indoxyl sulfate correlated with stage of chronic kidney disease in renal transplant recipients. Huang ST; Shu KH; Cheng CH; Wu MJ; Yu TM; Chuang YW; Chen CH Transplant Proc; 2012 Apr; 44(3):621-4. PubMed ID: 22483453 [TBL] [Abstract][Full Text] [Related]